Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure
This study has been completed.
Study NCT00259116   Information provided by Corthera, Inc.
First Received: November 28, 2005   Last Updated: April 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Failure, Congestive
Additional conditions recognized in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
Relaxin
Additional drug interventions recognized in this trial
Methocarbamol
More general drug interventions related to this trial
Central Nervous System Agents
Muscle Relaxants, Central
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Corthera, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services